PharmExec
CONTINUE TO SITE >

OR WAIT 15 SECS

Dennis Fournogerakis

Dennis Fournogerakis is an associate partner at Beghou Consulting.

Articles

To Reduce Commercial Risk for Orphan Drugs, Transform Forecasting

To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.